BOTOX® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and Or procerus muscle activity in adult patients < 65 years of age.
BOTOX® Cosmetic (onabotulinumtoxinA) for injection, is a sterile, vacuum-dried purified botulinum toxin type A. produced from fermentation of Hall strain Clostridium botulinum type A grown in a medium containing casein hydrolysate, glucose, and yeast extract, intended for intramuscular use- BOTOX® Cosmetic blocks neuromuscular transmission by binding to acceptor sites on motor nerve terminals. entering the nerve terminals, and inhibiting the release of acetylcholine- This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings. When injected intramuscularly at therapeutic doses, BOTOX® Cosmetic produces partial chemical denervation of the muscle resulting in a localized reduction in muscle activity-
Administration of BOTOX® Cosmetic is not recommended during pregnancy. There are no adequate and wellcontrolled studies of BOTOX® Cosmetic in pregnant womem It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when BOTOX® Cosmetic is administered to a nursing woman.